FDAnews Announces — Transforming Pharmacovigilance from Operational to Scientifically-driven Sponsored by Veeva Systems, May 6, 2020

Share Article

Drive operational efficiencies and streamline safety science - learn how. Register today, Join us and Register here.

WCG FDAnews

WCG FDAnews

Transforming Pharmacovigilance from Operational to Scientifically-driven
A Free FDAnews Webinar, Sponsored by Veeva Systems
Wednesday, May 6, 2020 • 11:00 a.m. - 12:00 p.m. EDT
http://info.fdanews.com/transforming-pharmacovigilance

With industry focus on patient-centric care, biopharmas are challenged on how to allocate more resources to the science of signal detection, epidemiology, and risk management. By enabling safety teams to provide faster, more comprehensive benefit-risk assessment, companies can improve patient’s lives.

Join us for a webinar on Wednesday, May 6 where we will discuss:

  • Approaches and benefits to moving from operational to scientifically-driven pharmacovigilance
  • Common challenges, including data quality and team skillset, and how to address them
  • Advancements in modern technologies to drive operational efficiencies and streamline safety science

We look forward to discussing this topic!

Webinar Details:
Transforming Pharmacovigilance from Operational to Scientifically-driven
A Free FDAnews Webinar, Sponsored by Veeva Systems
Wednesday, May 6, 2020 • 11:00 a.m. - 12:00 p.m. EDT
http://info.fdanews.com/transforming-pharmacovigilance

Easy Ways to Register:
Online: http://info.fdanews.com/transforming-pharmacovigilance
By phone: 888.838.5578 or 703.538.7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michelle Butler
FDAnews
703.538.7600
Email >
Visit website